View Clinical Trial (Medical Research Study)
Efficacy, Safety and Tolerability of AEB071 Versus Cyclosporine in the Novo Renal Transplant Recipients - NCT00504543-Praha - 008(Clinical Trial 177930)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials
| City: |
|
Praha |
|
Country:
|
|
Czech Republic |
|
|
|
| Conditions: |
|
Kidney Transplantation |
| Purpose: |
|
This study will assess safety and efficacy of AEB071 combined with everolimus in a CNI-free
(calcineurin inhibitor) regimen in renal transplant recipients.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion criteria
- Male and female patients 18 years or older
- Recipients of first kidney transplant from a deceased or living not related donor
Exclusion criteria
- Need for medication prohibited in the study
- Patients with heart disease (own or family history)
- Patients or donor HIV, Hepatitis B (HBsAg) or Hepatitis C (HCV) positive
- Patients with high immunological risks
- Patients with a history of cancer
- Other protocol-defined inclusion/exclusion criteria may apply |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
July 21, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|